Related Experiment Video

Updated: May 16, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

[Predictive factors of virological response in chronically HCV infected]

Tadeusz Wojciech Lapiński1, Robert Flisiak

  • 1Department of Infectious Diseases and Hepathology, Medical University of Bialystok, Poland. doctors@umwb.edu.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|November 20, 2012
PubMed

Insights

Predicting Hepatitis C virus (HCV) treatment success involves more than just antiviral drugs. Host factors like genetics, CXCL10 levels, and vitamin D may predict cure rates, with early viral response being key.

Area of Science:

  • Hepatology and Virology
  • Pharmacogenomics
  • Immunology

Context:

  • Chronic Hepatitis C virus (HCV) infection presents treatment challenges, as even advanced antiviral therapies lack guaranteed 100% efficacy.
  • Identifying predictors of treatment success is crucial for optimizing patient outcomes in HCV management.
  • While viral factors are known, host-dependent factors are increasingly recognized for their predictive value.

Purpose:

  • To explore host-dependent factors that predict the efficacy of antiviral drug treatment in chronically HCV-infected patients.
  • To investigate the role of specific genetic polymorphisms (rs12979860), chemokine levels (CXCL10/IP-10), and vitamin D concentration in predicting treatment response.

Summary:

  • Antiviral drug efficacy for chronic HCV is not absolute; early viral clearance at 4 and 12 weeks indicates a high probability of cure.
  • Host genetic factors, notably polymorphism rs12979860, and chemokines like CXCL10 (IP-10) show a predictive role in treatment success.
  • Vitamin D levels and early on-treatment viral response are also significant factors influencing treatment outcomes.

Impact:

  • This research highlights the importance of host factors in personalized HCV treatment strategies.
  • Understanding these predictors can lead to more tailored and effective therapeutic approaches for HCV.
  • Early on-treatment viral response is identified as a potentially crucial factor for future predictive models in HCV therapy.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...